Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-19 of 19 for Cardiomyopathy

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study of the Effect of Myectomy on the Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy

    Rochester, MN

  2. A Study to Evaluate Cardiopulmonary Exercise Testing in Liver Transplant Candidates

    Scottsdale/Phoenix, AZ

  3. A Study of the Impact of Cardiac Rehabilitation after Myectomy Procedure for Hypertrophic Cardiomyopathy

    Rochester, MN

  4. A Study to Assess Measurements in Cardiomyopathy Patients Using Software for Multi-level Reconstruction of Three Dimensional Transesophageal Echocardiography (TEE) or Transthoracic Echocardiography (TTE) Images

    Rochester, MN

  5. A Study to Evaluate if Modifications to the Kansas City Cardiomyopathy Questionnaire Are Needed to Address Interpretation Differences by Gender

    Rochester, MN

  6. Analysis of Outcomes of Left Cardiac Sympathetic Denervation in Arrhythmia Syndromes and Cardiomyopathies

    Rochester, MN

  7. Patient-Specific Induced Pluripotent Stem Cell Models for Heritable Channelopathies and Cardiomyopathies

    Rochester, MN

  8. A Study to Determine the Incidence of Atrial and Ventricular Arrhythmias in Patients with Hypertrophic Cardiomyopathy

    Rochester, MN

  9. A Study to Evaluate Heart Failure Biomarker to Predict Cardiomyopathy After Acute Radiation

    Jacksonville, FL


Mayo Clinic Footer